- Home
- Publications
- Publication Search
- Publication Details
Title
Defining active progressive multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 23, Issue 13, Pages 1727-1735
Publisher
SAGE Publications
Online
2017-08-23
DOI
10.1177/1352458517726592
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis
- (2016) Joachim Burman et al. JOURNAL OF NEUROIMMUNOLOGY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis
- (2015) Rikke Ratzer et al. Multiple Sclerosis Journal
- Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis
- (2015) Rikke Ratzer et al. Multiple Sclerosis Journal
- CSF levels of YKL-40 are increased in MS and decrease with immunosuppressive treatment
- (2014) Clas Malmeström et al. JOURNAL OF NEUROIMMUNOLOGY
- N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis
- (2014) Alessandro Trentini et al. JOURNAL OF NEUROLOGY
- Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial
- (2014) J. Romme Christensen et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
- (2013) Markus Axelsson et al. Multiple Sclerosis Journal
- Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
- (2013) Mohsen Khademi et al. PLoS One
- Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis
- (2013) Keith R. Edwards et al. PLoS One
- Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis
- (2013) Signe Modvig et al. PLoS One
- CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
- (2012) Jeppe Romme Christensen et al. Multiple Sclerosis Journal
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis
- (2010) Jorge Correale et al. Multiple Sclerosis Journal
- Neurofilament light as a prognostic marker in multiple sclerosis
- (2010) Jonatan Salzer et al. Multiple Sclerosis Journal
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- EFNS guidelines on disease-specific CSF investigations
- (2009) F. Deisenhammer et al. EUROPEAN JOURNAL OF NEUROLOGY
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started